Efficacy and safety comparison of Helicobacter pylori eradication between vonoprazan dual therapy versus triple therapy: a systematic review and meta-analysis

BACKGROUND: As a novel drug, vonoprazan (VPZ) has been developed as a new strategy against Helicobacter pylori (H. pylori) infections. However, whether VPZ + amoxicillin (AMO) dual therapy has a clear advantage is still unclear. OBJECTIVE: To review and meta-analyze the available literature investig...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Zheyu, Wang, Fen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2022
Materias:
Meta-Analysis
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9577096/
https://www.ncbi.nlm.nih.gov/pubmed/36268270
http://dx.doi.org/10.1177/17562848221125308

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9577096/
https://www.ncbi.nlm.nih.gov/pubmed/36268270
http://dx.doi.org/10.1177/17562848221125308

Ejemplares similares